Racho, Krizzia Zahirah A.

HRN: 26-87-40  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/28/2025
CO-AMOXICLAV 457MG/5ML, 70ML SUSPENSION (BOT)
03/28/2025
04/04/2025
PO
0.8 Ml
Q 12
UTI
Waiting Final Action 

Indication:  Empiric    Type of Infection:  Urinary Tract    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: